Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact
Search
Close

The American Health Care Act, the Sequel Receives Its CBO Grade

By Robert E. Slavkin on May 25, 2017
Email this postTweet this postLike this postShare this post on LinkedIn

Perhaps the high fives in the Rose Garden of the White House a few weeks ago may have been a bit premature. On Wednesday, May 24, 2017, the non-partisan Congressional Budget Office (CBO) released its analysis of the revised American Health Care Act (AHCA), and the review contained positive budgetary news, but the overall impact of the bill on health insurance in the country is a larger question.

First, the budgetary news. Because the Senate has chosen to pass healthcare reform legislation through the reconciliation process, any bill ultimately passed by the Senate must demonstrate that it has a zero to positive impact on the federal budget. The CBO found that the original bill from March 2017, would have insured 24 million fewer people, but would save $150 billion taxpayer dollars. The revised bill, by contrast, will insure 23 million fewer individuals but save $119 billion taxpayer dollars, according to the CBO.

The potential impact on the country, however, is the subject of a significant debate that will influence where the bill goes from here. As stated above, the CBO states that after a decade, AHCA would insure 23 million fewer people than the current law, the Affordable Care Act (ACA). The bill could also negatively impact many people with pre-existing conditions, who are currently protected under the ACA. The CBO indicated that some citizens would see lower insurance premiums, but many others, including those with pre-existing conditions, may not be able to afford health insurance, due to significantly higher premiums.

For example, a 64 year-old who makes $26,500/year would pay $13,600 – $16,100 per year in insurance premiums. Under the current law, that person pays approximately $1,700 per year in premiums. The current law limits what insurers can charge and provides subsidies to the taxpayer, so insurance is more affordable.

Also, under the AHCA, states could choose to opt-out of the ACA’s ‘essential health benefits’ requirement, where insurers must cover certain categories including hospital stays, maternity and newborn care, as well as prescription medications. The CBO indicated approximately 1/6 of the nation’s population, or approximately 51 million people, could see significantly reduced insurance benefits as a result.

Additionally, the revised AHCA cuts Medicaid spending by $800 billion, causing 14 million fewer people to be enrolled in ten years. This savings comes from repealing the ACA taxes on high-income earners and medical companies. It also halts the penalty for those who do not purchase insurance and for employers who do not provide insurance coverage to their employees. These taxes and penalties helped fund the Medicaid expansion under the ACA.

The Senate has begun work on its own healthcare legislation. All indications are that the upper chamber of Congress will take a more  systematic approach to drafting legislation. The CBO score of the revised AHCA will undoubtedly add fuel to a summer of meetings, hearings, and soundbites from Washington, D.C. We will continue to monitor this developing story and publish updates as necessary.

Photo of Robert E. Slavkin Robert E. Slavkin

Robert Slavkin is the chair of the Healthcare Practice Group, a multidisciplinary team recognized nationally for representing sector participants in regulatory compliance, insurance, and transactional issues. A former healthcare corporate counsel, compliance, and privacy officer for a publicly traded healthcare company, Robert represents…

Robert Slavkin is the chair of the Healthcare Practice Group, a multidisciplinary team recognized nationally for representing sector participants in regulatory compliance, insurance, and transactional issues. A former healthcare corporate counsel, compliance, and privacy officer for a publicly traded healthcare company, Robert represents a variety of clients within the healthcare sector, providing guidance on complex issues and compliance with all appropriate federal and state statutes and regulations. These include federal anti-kickback, Stark laws, Medicare, Medicaid, HIPAA, and FDA regulations, as well as providing guidance on daily operational and compliance issues facing healthcare entities. Robert has significant experience with the Affordable Care Act and the ever-evolving role accountable care plays in U.S. health reform. Additionally, Robert counsels clients on Medicare Managed Care and the Part D programs. He possesses a keen understanding of the momentous legislative changes of this sector as well as potential resulting implications.

Read more about Robert E. SlavkinEmail
Show more Show less
  • Posted in:
    Health Care and Life Sciences
  • Blog:
    Health Law Rx
  • Organization:
    Akerman LLP
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
The Library at LexBlog
  • About LexBlog
  • The Field We Built
  • Library at LexBlog
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo